Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
Related Posts
Gunsalus RP, Humm E, Cook L, Wofford NQ, James KL, Pellegrini M, Morselli M, Ha SM, McInerney MJ. Whole genome sequence of the syntrophic benzoate-degrading[...]
Ahmad E, Ahmad S, Naeem A, Ahmed S, Shehzad M, Akram U, Ashraf H, Rehman OU, Ullah I, Ahmed R, Alraies C, Fonarow GC. Trends[...]
Asada H, Takami M, Mori S, Izawa Y, Kawamori H, Fukuzawa K. Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation. JACC[...]